Prevest Denpro (BOM:543363) ROCE %: 24.78% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543363 Prevest Denpro Ltd BOM:543363
84 GF Score
Price ₹390.00
GF Value ₹622.13
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Prevest Denpro ROCE %?

Prevest Denpro BOM:543363 +0.78% 84 ROCE % is 24.78% as of Mar. 2026. GuruFocus rates BOM:543363 with a GF Score™ of 84/100 and a GF Value™ of ₹622.13 (Possible Value Trap). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Prevest Denpro's annualized ROCE % for the quarter that ended in Mar. 2026 was 24.78%.


Prevest Denpro  (BOM:543363) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Prevest Denpro ROCE % Related Terms


Prevest Denpro ROCE % Historical Data

* Premium members only.

The historical data trend for Prevest Denpro's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prevest Denpro ROCE % Chart

Prevest Denpro Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 38.99 63.36 44.32 24.76 23.74

Prevest Denpro Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.84 22.48 25.28 22.09 24.78
BOM:543363
84GF Score
Prevest Denpro Ltd BOM:543363
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prevest Denpro ROCE % Calculation

Prevest Denpro's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=276.123/( ( (1125.286 - 59.617) + (1331.907 - 71.414) )/ 2 )
=276.123/( (1065.669+1260.493)/ 2 )
=276.123/1163.081
=23.74 %

Prevest Denpro's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=312.4/( ( (0 - 0) + (1331.907 - 71.414) )/ 1 )
=312.4/( ( 0 + 1260.493 )/ 1 )
=312.4/1260.493
=24.78 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 24.78% mean?
Prevest Denpro (BOM:543363) has a ROCE % of 24.78% as of Mar. 2026.
Is Prevest Denpro's ROCE % too high?
Prevest Denpro's current ROCE % is 24.78%. The Medical Devices & Instruments industry median ROCE % is 2.22. Prevest Denpro's value of 24.78% is 1016.2% above this industry median. Overall, Prevest Denpro has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's ROCE % compare to ISRG and BDX?
Prevest Denpro's ROCE % of 24.78% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.22. Prevest Denpro's value of 24.78% is 1016.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.22, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prevest Denpro's current ROCE % of 24.78% is 1016.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prevest Denpro's current ROCE % is 24.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹622.13, compared to a current price of ₹390.00 — trading 37.3% below its estimated fair value. The current ROCE % is 24.78% and 1016.2% above the Medical Devices & Instruments industry median of 2.22. Prevest Denpro's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current ROCE % is 24.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prevest Denpro (BOM:543363) Overvalued in 2026?

Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued. The current stock price of ₹390.00 is trading 37.3% below its estimated GF Value™ of ₹622.13. GuruFocus considers Prevest Denpro to be Possible Value Trap.

Key valuation signals for BOM:543363:

  • ROCE %: 24.78%
  • GF Value™: ₹622.13 vs. price of ₹390.00 (37.3% below fair value)
  • GF Score™: 84/100 with 3 warning signs
  • Industry Position: 1016.2% above the Medical Devices & Instruments median

No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Prevest Denpro Business Description

Address EPIP, Kartholi, Bari Brahmana, Samba, Jammu & Kashmir, HP, IND, 181133
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
84GF Score

Get the complete analysis for BOM:543363

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹390.00
Price
₹622.13
GF Value